291 related articles for article (PubMed ID: 18042110)
21. Methotrexate for maintaining remission in paediatric Crohn's patients with prior failure or intolerance to thiopurines: a multicenter cohort study.
Haisma SM; Lijftogt T; Kindermann A; Damen G; de Ridder L; Escher JC; Mearin ML; de Meij T; Hendriks D; George E; Hummel T; Norbruis O; van Rheenen P
J Crohns Colitis; 2015 Apr; 9(4):305-11. PubMed ID: 25656249
[TBL] [Abstract][Full Text] [Related]
22. Natural history of Crohn's disease in a population-based cohort from Cardiff (1986-2003): a study of changes in medical treatment and surgical resection rates.
Ramadas AV; Gunesh S; Thomas GA; Williams GT; Hawthorne AB
Gut; 2010 Sep; 59(9):1200-6. PubMed ID: 20650924
[TBL] [Abstract][Full Text] [Related]
23. Sustained clinical benefit and tolerability of methotrexate monotherapy after thiopurine therapy in patients with Crohn's disease.
Seinen ML; Ponsioen CY; de Boer NK; Oldenburg B; Bouma G; Mulder CJ; van Bodegraven AA
Clin Gastroenterol Hepatol; 2013 Jun; 11(6):667-72. PubMed ID: 23333660
[TBL] [Abstract][Full Text] [Related]
24. Long-term methotrexate for Crohn's disease: safety and efficacy in clinical practice.
Domènech E; Mañosa M; Navarro M; Masnou H; Garcia-Planella E; Zabana Y; Cabré E; Gassull MA
J Clin Gastroenterol; 2008 Apr; 42(4):395-9. PubMed ID: 18277899
[TBL] [Abstract][Full Text] [Related]
25. Adherence to thiopurine treatment in out-patients with Crohn's disease.
Bokemeyer B; Teml A; Roggel C; Hartmann P; Fischer C; Schaeffeler E; Schwab M
Aliment Pharmacol Ther; 2007 Jul; 26(2):217-25. PubMed ID: 17593067
[TBL] [Abstract][Full Text] [Related]
26. Immunosuppressive drugs in Crohn's disease.
Kornbluth A; George J; Sachar DB
Gastroenterologist; 1994 Sep; 2(3):239-46. PubMed ID: 7987622
[TBL] [Abstract][Full Text] [Related]
27. 6-Thioguanine therapy in Crohn's disease--observational data in Swedish patients.
Almer SH; Hjortswang H; Hindorf U
Dig Liver Dis; 2009 Mar; 41(3):194-200. PubMed ID: 18799369
[TBL] [Abstract][Full Text] [Related]
28. A multicenter, randomized, double-blind trial of everolimus versus azathioprine and placebo to maintain steroid-induced remission in patients with moderate-to-severe active Crohn's disease.
Reinisch W; Panés J; Lémann M; Schreiber S; Feagan B; Schmidt S; Sturniolo GC; Mikhailova T; Alexeeva O; Sanna L; Haas T; Korom S; Mayer H
Am J Gastroenterol; 2008 Sep; 103(9):2284-92. PubMed ID: 18671816
[TBL] [Abstract][Full Text] [Related]
29. A single center experience of methotrexate in the treatment of Crohn's disease and ulcerative colitis: a case for subcutaneous administration.
Nathan DM; Iser JH; Gibson PR
J Gastroenterol Hepatol; 2008 Jun; 23(6):954-8. PubMed ID: 17559377
[TBL] [Abstract][Full Text] [Related]
30. Autologous haematopoietic stem cell transplantation without CD34+ cell selection in refractory Crohn's disease.
Cassinotti A; Annaloro C; Ardizzone S; Onida F; Della Volpe A; Clerici M; Usardi P; Greco S; Maconi G; Porro GB; Deliliers GL
Gut; 2008 Feb; 57(2):211-7. PubMed ID: 17895357
[TBL] [Abstract][Full Text] [Related]
31. Tacrolimus therapy as an alternative to thiopurines for maintaining remission in patients with refractory ulcerative colitis.
Yamamoto S; Nakase H; Matsuura M; Masuda S; Inui K; Chiba T
J Clin Gastroenterol; 2011 Jul; 45(6):526-30. PubMed ID: 21336140
[TBL] [Abstract][Full Text] [Related]
32. [Response to stopping azathioprine in Crohn's patients on combined treatment with infliximab].
Martín De Carpi J; Varea V
An Pediatr (Barc); 2009 Mar; 70(3):271-7. PubMed ID: 19409244
[TBL] [Abstract][Full Text] [Related]
33. Methotrexate is an efficient therapeutic alternative in children with thiopurine-resistant Crohn's disease.
Hojsak I; Mišak Z; Jadrešin O; Močić Pavić A; Kolaček S
Scand J Gastroenterol; 2015; 50(10):1208-13. PubMed ID: 25877164
[TBL] [Abstract][Full Text] [Related]
34. Higher Mucosal Healing with Tumor Necrosis Factor Inhibitors in Combination with Thiopurines Compared to Methotrexate in Crohn's Disease.
Vasudevan A; Raghunath A; Anthony S; Scanlon C; Sparrow MP; Gibson PR; van Langenberg DR
Dig Dis Sci; 2019 Jun; 64(6):1622-1631. PubMed ID: 30560332
[TBL] [Abstract][Full Text] [Related]
35. Addition of thiopurines can recapture response in patients with Crohn's disease who have lost response to anti-tumor necrosis factor monotherapy.
Ong DE; Kamm MA; Hartono JL; Lust M
J Gastroenterol Hepatol; 2013 Oct; 28(10):1595-9. PubMed ID: 23662928
[TBL] [Abstract][Full Text] [Related]
36. Azathioprine therapy in steroid-dependent patients with Crohn disease: results of a 10-year longitudinal follow-up study.
Pinto AL; Chebli LA; Ribeiro MS; Pace FH; Moraes JP; do Amaral FJ; Gaburri PD; Meirelles de Souza AF; Chebli JM
Med Sci Monit; 2009 May; 15(5):PI19-26. PubMed ID: 19396048
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of azathioprine in the treatment of chronic active Crohn's disease: prospective one-year follow-up study. German Imurek Study Group.
Ludwig D; Stange EF
Z Gastroenterol; 1999 Nov; 37(11):1085-91. PubMed ID: 10604222
[TBL] [Abstract][Full Text] [Related]
38. Tolerability and safety of mercaptopurine in azathioprine-intolerant patients with inflammatory bowel disease.
Lees CW; Maan AK; Hansoti B; Satsangi J; Arnott ID
Aliment Pharmacol Ther; 2008 Feb; 27(3):220-7. PubMed ID: 17988235
[TBL] [Abstract][Full Text] [Related]
39. Long-term outcome of Crohn's disease following corticosteroid-induced remission.
Papi C; Festa V; Leandro G; Moretti A; Tanga M; Koch M; Capurso L
Am J Gastroenterol; 2007 Apr; 102(4):814-9. PubMed ID: 17222316
[TBL] [Abstract][Full Text] [Related]
40. Thiopurines in Crohn's disease, is there something new?
Miheller P; Lakatos PL
Expert Opin Drug Metab Toxicol; 2010 Dec; 6(12):1505-14. PubMed ID: 20919963
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
